PRAIS 2.0 – Regional Platform on Access and Innovation for Health Technologies

New clinical guidelines aim to improve care for severe yellow fever patients in the Americas

admin - 19:45, 26 de March de 202657

New clinical guidelines aim to improve care for severe yellow fever patients in the Americas

Cristina Mitchell

27 Mar 2026

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

Murilo Freitas - 22:47, 25 de March de 202672

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i

Local capacity key to ensure global pandemic preparedness, PAHO Director says in New York

admin - 19:58, 25 de March de 202648

Local capacity key to ensure global pandemic preparedness, PAHO Director says in New York

Oscar Reyes

26 Mar 2026

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome

Murilo Freitas - 15:24, 24 de March de 202654

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
http://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-neurologic-manifestations-hunter-syndrome

Cryoprobe Recall: Erbe USA Removes Flexible Cryoprobes

Murilo Freitas - 04:00, 24 de March de 2026113

Erbe Cryoprobes may rupture during activation, leading to potential hearing loss, tinnitus, injury, or burns.

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/cryoprobe-recall-erbe-usa-removes-flexible-cryoprobes

Heating Pad Recall: Navajo Manufacturing Company Removes Handy Solutions Neck & Shoulders Heating Pad

Murilo Freitas - 04:00, 24 de March de 2026112

Navajo Manufacturing company is recalling certain heating pads that overheat when folded leading to potential burn injuries.

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/heating-pad-recall-navajo-manufacturing-company-removes-handy-solutions-neck-shoulders-heating-pad

World Tuberculosis Day 2026: Primary health care key to a more accessible, people-centered response

admin - 15:19, 23 de March de 202653

World Tuberculosis Day 2026: Primary health care key to a more accessible, people-centered response

Oscar Reyes

24 Mar 2026

Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) Due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL

Murilo Freitas - 04:00, 23 de March de 2026210

Bridgewater, New Jersey, Amneal Pharmaceuticals LLC is voluntarily recalling one lot of Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, to the hospital level. A Magnesium Sulfate in Water for Injection pouch was found to contain an IV bag of Tranexamic Acid in 0.7% Sodium Chloride I

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-magnesium-sulfate-water-injection-usp

PAHO and Global Affairs Canada renew CAD$15 million partnership to advance women’s and adolescents’ health in the Americas

admin - 19:40, 22 de March de 202660

PAHO and Global Affairs Canada renew CAD$15 million partnership to advance women’s and adolescents’ health in the Americas

Cristina Mitchell

23 Mar 2026

Guatemala se incorpora a la Alianza por la Atención Primaria de Salud de las Américas para fortalecer su sistema sanitario

admin - 20:37, 19 de March de 2026412

Guatemala joins the Alliance for Primary Health Care in the Americas to strengthen its health system

Cristina Mitchell

20 Mar 2026

PRAIS 2.0